Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Anxiety Disorders 1Adjustment Disorders 1

Interventions

Psilocybin 5Psychotherapy 2Fluoxetine 2Cannabidiol 2nabiximols 1Yoga 1Therapeutics 1Sertraline 1Self-Management 1Selective Serotonin Reuptake Inhibitors 1Professional Autonomy 1Pharmaceutical Preparations 1Niacin 1Neoadjuvant Therapy 1N-Methyl-3,4-methylenedioxyamphetamine 1Minocycline 1Medical Marijuana 1Ketamine 1Injections 1Hormones 1Gemcitabine 1Exercise 1Dronabinol 1Donepezil 1Clomipramine 1Citalopram 1Cisplatin 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anxiety Disorders × N-Methyl-3,4-methylenedioxyamphetamine × Clear all
NCT00252174 2017-11-14

MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

Brigham and Women's Hospital

Phase 2 Terminated
2 enrolled 6 charts

Anxiety Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡